Clinical Trials Directory

Trials / Completed

CompletedNCT04649424

COVID-19 Nasal Swab Trial

Comparative Evaluation of Nasopharyngeal Swabs for Sampling and Detection of SARS-CoV2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Orthopaedic Innovation Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.

Detailed description

Compare the Precision ADM "CanSwab" nasopharyngeal swab to a conventional nylon-flocked nasopharyngeal swab on the basis of: 1. The amount of SARS-CoV2 virus (COVID-19) collected by swabs, measured in CT (thermal cycles) 2. Clinical concordance rate 3. Patient comfort during nasopharyngeal sampling procedure

Conditions

Interventions

TypeNameDescription
DEVICECanSwabNew nasopharyngeal swab design.

Timeline

Start date
2020-12-22
Primary completion
2021-04-13
Completion
2021-04-13
First posted
2020-12-02
Last updated
2021-07-15

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT04649424. Inclusion in this directory is not an endorsement.

COVID-19 Nasal Swab Trial (NCT04649424) · Clinical Trials Directory